Drug-Induced Hypoglycemia

Key points
- A number of drugs apart from the sulfonylureas can occasionally cause hypoglycemia, especially when ingested in large amounts.
- Recently, it has been reported that the use of gatifloxacin in diabetic patients is associated with serious hypoglycemic and hyperglycemic reactions.
- Ten to 20 percent of patients receiving pentamidine for Pneumocystis jiroveci pneumonia develop symptomatic hypoglycemia, particularly when the drug is administered intravenously.
- This apparently is due to lytic destruction of pancreatic B cells, causing acute hyperinsulinemia and hypoglycemia.
A number of drugs apart from the sulfonylureas can occasionally cause hypoglycemia, especially when ingested in large amounts. These include quinine, quinidine, disopyramide, and salicylates. ACE inhibitors, when taken with antidiabetic drugs, can cause hypoglycemia possibly by improving insulin sensitivity.
Recently, it has been reported that the use of gatifloxacin in diabetic patients is associated with serious hypoglycemic and hyperglycemic reactions.
Ten to 20 percent of patients receiving pentamidine for Pneumocystis jiroveci pneumonia develop symptomatic hypoglycemia, particularly when the drug is administered intravenously.
This apparently is due to lytic destruction of pancreatic B cells, causing acute hyperinsulinemia and hypoglycemia.
It is later followed by insulinopenia and hyperglycemia, which occasionally is persistent. Since other drugs have been found to be as effective in treating Pneumocystis pneumonia, pentamidine administration and its hypoglycemic sequelae are less frequently encountered.
{embed="db/static-menu-hypoglycemia"}
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsCan drug coverage erase the income gap in diabetes?
Universal drug coverage might help partly close the gap between the rich and the poor when it comes to diabetes complications, a new Canadian study suggests. Researchers found that much of the income gap in heart risks…
1 September 2012
NewsSalk study may offer drug-free intervention to prevent obesity and diabetes
-It turns out that when we eat may be as important as what we eat. Scientists at the Salk Institute for Biological Studies have found that regular eating times and extending the daily fasting period may override the…
18 May 2012
NewsNew inflammation hormone link may pave way to study new drugs for type 2 diabetes
A new link between obesity and type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes, University of Michigan Health System research has found. Drugs for type 2…






